Ozempic, a medication originally designed to manage Type 2 diabetes, has gained widespread attention for its weight loss effects. By slowing digestion and promoting a sense of fullness, the drug has become a popular off-label tool for people seeking to shed pounds. While its effectiveness is well-documented, a new and surprising side effect has begun to emerge.

Social media users and some medical professionals are raising concerns about a phenomenon now dubbed the “Ozempic vulva.” This unofficial term refers to noticeable changes in the vaginal area, including sagging labia, reduced muscle tone, and dryness. Though not formally recognized in medical literature, these reports align with experts’ observations on how rapid fat and muscle loss can impact delicate pelvic and vaginal tissues.

Doctors believe several factors may contribute to these changes. Rapid weight loss can lead to a decrease in supportive fat around the pelvic region, which may result in structural changes. In addition, dehydration and hormonal fluctuations—both potential side effects of Ozempic—may further impact vaginal health and tissue integrity.

As awareness grows, some women are turning to cosmetic interventions to address the issue. Procedures like vaginal rejuvenation and dermal fillers are being used to restore volume and improve muscle tone in the affected areas. However, these options can be costly and are not without risk.

It’s important to note that not all Ozempic users experience these side effects. However, the growing number of anecdotal reports has sparked a broader conversation about how weight-loss medications might affect the body in unexpected ways, particularly in areas that are less frequently discussed.

The emergence of “Ozempic vulva” underscores the need for further research. As the drug’s popularity continues to rise, healthcare providers and users alike must stay informed about both its benefits and its potential complications.